A Message from Veracyte’s CEO About COVID-19     Learn More
A Message from Veracyte’s CEO About COVID-19     Learn More
Skip to content
PRESS RELEASES

PRESS RELEASES

Date Title and Summary Additional Formats
Toggle Summary Veracyte Announces Proposed Public Offering of Common Stock
SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Aug. 3, 2020-- Veracyte, Inc. (Nasdaq: VCYT) (the “Company”) today announced that it has commenced an underwritten public offering of 6,000,000 shares of its common stock. All of the shares are being offered by Veracyte .
View HTML
Toggle Summary Veracyte Announces Second Quarter 2020 Financial Results
Revenue of $20.7 Million and Genomic Testing Volume of 5,379 Company Advances Pipeline and Global Expansion Strategy Conference Call and Webcast Today at 4:30 p.m. ET SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Jul. 30, 2020-- Veracyte, Inc . (Nasdaq: VCYT) today announced financial results for
View HTML
Toggle Summary Veracyte Announces Data Published in AJRCCM Showing That the Envisia Genomic Classifier Improves Physicians’ Ability to Diagnose IPF Without Surgery
SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Jul. 30, 2020-- Veracyte, Inc . (Nasdaq: VCYT) today announced new study results showing that use of the Envisia ® Genomic Classifier improves physicians’ ability to diagnose idiopathic pulmonary fibrosis (IPF) and other interstitial lung diseases
View HTML
Toggle Summary Veracyte and MAVIDx Announce Agreement for MAVIDx to Develop Ultra-High Volume COVID-19 Testing on the nCounter System
Novel approach may enable processing of over 40,000 patient samples per day using molecular barcodes for viral RNA SOUTH SAN FRANCISCO, Calif. , and MIAMI --(BUSINESS WIRE)--Jul. 29, 2020-- Veracyte, Inc . (Nasdaq: VCYT) and MAVIDx today announced an agreement for MAVIDx to develop ultra-high
View HTML
Toggle Summary Veracyte Appoints Jens Holstein to Board of Directors and James (Jim) Erlinger as Executive Vice President, General Counsel and Secretary
SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Jul. 27, 2020-- Veracyte, Inc. (Nasdaq: VCYT), a global genomic diagnostics company, today announced the addition of Jens Holstein to the company’s board of directors and the appointment of Jim Erlinger as executive vice president, general counsel and
View HTML
Toggle Summary Veracyte to Release Second Quarter 2020 Financial Results on July 30, 2020
SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Jul. 16, 2020-- Veracyte, Inc . (Nasdaq: VCYT) announced today that it will release its financial results for the second quarter of 2020 after the close of market on Thursday, July 30, 2020 . Company management will host a conference call and webcast
View HTML
Toggle Summary Veracyte Announces Clinical Utility Study Published in CHEST Demonstrates Envisia Genomic Classifier’s Ability to Improve IPF Diagnosis
SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Jun. 11, 2020-- Veracyte, Inc . (Nasdaq: VCYT) announced today the publication of an independent study showing that the Envisia Genomic Classifier enables physicians to more confidently diagnose idiopathic pulmonary fibrosis (IPF), a progressive lung
View HTML
Toggle Summary Veracyte Announces De Novo Classification Request to FDA for the nCounter Dx LymphMark Assay
SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Jun. 9, 2020-- Veracyte, Inc . (Nasdaq: VCYT) today announced its submission of a De Novo classification request to the U.S. Food & Drug Administration (FDA) for the nCounter ® Dx LymphMark ™ Assay, a novel, genomic lymphoma subtyping test.
View HTML
Toggle Summary Veracyte to Present at the William Blair 40th Annual Growth Stock Conference
SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--May 27, 2020-- Veracyte, Inc . (Nasdaq: VCYT) announced today that Bonnie H. Anderson , chairman and chief executive officer, is scheduled to present virtually at the William Blair 40th Annual Growth Stock Conference on Wednesday, June 10 , at 12:40
View HTML
Toggle Summary Veracyte to Present at the Jefferies Virtual Healthcare Conference
SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--May 21, 2020-- Veracyte, Inc . (Nasdaq: VCYT) announced today that Bonnie H. Anderson , chairman and chief executive officer, is scheduled to present at the Jefferies Virtual Healthcare Conference on Wednesday, June 3, 2020 at 3:30 p.m. Eastern Time .
View HTML